Process View
Any process that activates or increases the frequency, rate, or extent of chemokine production.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of chemokine production"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MYD88 | myeloid differentiation primary response gene (88) | 0.995 | Mouse | |
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.978 | Mouse | |
| IL1R1 | interleukin 1 receptor, type I | 0.868 | ||
| TLR4 | toll-like receptor 4 | 0.827 | ||
| ABI2 | abl-interactor 2 | 0.798 | ||
| IRAK2 | interleukin-1 receptor-associated kinase 2 | 0.723 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.680 | ||
| LAT | linker for activation of T cells | 0.672 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.480 | Human | |
| IRAK1 | interleukin-1 receptor-associated kinase 1 | 0.408 | ||
| IL4R | interleukin 4 receptor | 0.300 | Mouse | |
| C1QA | complement component 1, q subcomponent, A chain | 0.291 | Human | |
| TLR2 | toll-like receptor 2 | 0.278 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.270 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.248 | Human | |
| IL1RAP | interleukin 1 receptor accessory protein | 0.220 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.212 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.207 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.191 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.170 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.145 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.144 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.122 | ||
| HDAC2 | histone deacetylase 2 | 0.120 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.109 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.103 | ||
| NRP1 | neuropilin 1 | 0.099 | ||
| TMEM173 | transmembrane protein 173 | 0.098 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.095 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.088 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.076 | ||
| APOE | apolipoprotein E | 0.070 | ||
| PGF | placental growth factor | 0.067 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.066 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.065 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.064 | ||
| SNX33 | sorting nexin 33 | 0.062 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.062 | ||
| IRAK3 | interleukin-1 receptor-associated kinase 3 | 0.057 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.053 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.052 | ||
| DLG1 | discs, large homolog 1 (Drosophila) | 0.051 | ||
| CFH | complement factor H | 0.051 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.050 | ||
| IL4 | interleukin 4 | 0.044 | Mouse | |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.043 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.043 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.043 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.042 | Human | |
| MEFV | Mediterranean fever | 0.039 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.038 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.037 | Human | |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.037 | ||
| MAFA | v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) | 0.036 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.036 | ||
| SH3D19 | SH3 domain containing 19 | 0.033 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.033 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.033 | ||
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.031 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.030 | ||
| CFI | complement factor I | 0.030 | ||
| JAK1 | Janus kinase 1 | 0.028 | ||
| CD14 | CD14 molecule | 0.027 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.026 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.026 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.026 | Human | |
| FZD1 | frizzled homolog 1 (Drosophila) | 0.025 | ||
| RUNX1 | runt-related transcription factor 1 | 0.025 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.024 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.024 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.024 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.024 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.024 | ||
| GATA2 | GATA binding protein 2 | 0.024 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.023 | ||
| IL1B | interleukin 1, beta | 0.022 | ||
| STC2 | stanniocalcin 2 | 0.022 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.022 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.021 | ||
| ALOX12B | arachidonate 12-lipoxygenase, 12R type | 0.021 | Human | |
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.020 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.020 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.018 | Human | |
| EGFR | epidermal growth factor receptor | 0.018 | ||
| LY96 | lymphocyte antigen 96 | 0.018 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.018 | ||
| IL6R | interleukin 6 receptor | 0.017 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.017 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.017 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.017 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.017 | ||
| HCK | hemopoietic cell kinase | 0.017 | ||
| HP | haptoglobin | 0.017 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.017 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.017 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.016 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.016 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.016 | ||
| KITLG | KIT ligand | 0.016 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.015 | ||
| MPO | myeloperoxidase | 0.015 | ||
| C1S | complement component 1, s subcomponent | 0.015 | ||
| SYK | spleen tyrosine kinase | 0.015 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.015 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.015 | ||
| NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.015 | ||
| SPRR2A | small proline-rich protein 2A | 0.014 | ||
| PTAFR | platelet-activating factor receptor | 0.014 | ||
| CLEC7A | C-type lectin domain family 7, member A | 0.014 | ||
| LDLR | low density lipoprotein receptor | 0.014 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.014 | ||
| XPO7 | exportin 7 | 0.014 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.014 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.014 | ||
| VEGFA | vascular endothelial growth factor A | 0.014 | ||
| IRF5 | interferon regulatory factor 5 | 0.014 | ||
| SAMHD1 | SAM domain and HD domain 1 | 0.014 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.014 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.014 | ||
| IL8 | interleukin 8 | 0.014 | ||
| CMIP | c-Maf-inducing protein | 0.013 | ||
| IFIH1 | interferon induced with helicase C domain 1 | 0.013 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.013 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.013 | ||
| IRS1 | insulin receptor substrate 1 | 0.013 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.012 | Human | |
| TLR7 | toll-like receptor 7 | 0.012 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.012 | ||
| ALOXE3 | arachidonate lipoxygenase 3 | 0.012 | Human | |
| TXN | thioredoxin | 0.012 | ||
| SLC15A3 | solute carrier family 15, member 3 | 0.012 | ||
| IRF8 | interferon regulatory factor 8 | 0.012 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.012 | ||
| CTSG | cathepsin G | 0.012 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.012 | ||
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.012 | ||
| C1R | complement component 1, r subcomponent | 0.012 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.011 | ||
| MPEG1 | macrophage expressed 1 | 0.011 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.011 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | Human | |
| KRT5 | keratin 5 | 0.011 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.011 | ||
| IRF7 | interferon regulatory factor 7 | 0.010 | ||
| MOV10 | Mov10, Moloney leukemia virus 10, homolog (mouse) | 0.010 |